FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

(MedPage Today) — Oncology specialists should inform patients about a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) deficiency and should test for DPYD variants before starting treatment with capecitabine (Xeloda) and…

Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/119774

Author :

Publish date : 2026-02-06 17:59:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

Intrusive thoughts? John has a room for that

Related Posts

Intrusive thoughts? John has a room for that

Emails Undermine RFK Jr.’s Testimony on His Trip to Samoa Before a Measles Outbreak

Use of GLP-1 Drugs Under Scrutiny at Winter Olympics

Kate Middleton’s Cancer Battle; RFK Jr. Claims Keto Can ‘Cure’; FDA Chief’s Warning

Comedy on Prescription? Pilot Raises Hopes for NHS Care

Study Maps Extensive Disease Links Beyond Childhood Eczema

FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

Intrusive thoughts? John has a room for that

Emails Undermine RFK Jr.’s Testimony on His Trip to Samoa Before a Measles Outbreak

Use of GLP-1 Drugs Under Scrutiny at Winter Olympics

Kate Middleton’s Cancer Battle; RFK Jr. Claims Keto Can ‘Cure’; FDA Chief’s Warning

Comedy on Prescription? Pilot Raises Hopes for NHS Care

Study Maps Extensive Disease Links Beyond Childhood Eczema

Home Visits Don’t Reduce Heat-Related ED Use in Older Adults

Categories

Archives